| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |